Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Relaxin, Matrix Metalloproteinase-2 and Interleukin-6 in Women With Chronic Pelvic Pain, Diagnosis of Deep Infiltrative Endometriosis and Investigation of it is Place in Follow-up

NCT06628479 is registered in ClinicalTrials.gov with Sanliurfa Mehmet Akif Inan Education and Research Hospital as lead sponsor.

NCT NCT06628479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06628479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Relaxin, Matrix Metalloproteinase-2 and Interleukin-6 in Women With Chronic Pelvic Pain, Diagnosis of Deep Infiltrative Endometriosis and Investigation of it is Place in Follow-up
Lead sponsor
Sanliurfa Mehmet Akif Inan Education and Research Hospital
Phase
Observational
Overall status
Completed
Start date
June 15, 2022
Completion date
June 15, 2023
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis